AP NEWS
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from NewMediaWire
Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Aemetis to Review Third Quarter Results on November 14, 2019

November 8, 2019 GMT

CUPERTINO, CA - ( NewMediaWire ) - November 08, 2019 - Aemetis, Inc.(NASDAQ: AMTX) announced that the company will host a conference call to review the release of its third quarter earnings report:

Date:   Thursday, November 14, 2019

Time:   11 am Pacific Standard Time (PST)

Live Participant Dial In (Toll Free):+1-844-407-9500

Live Participant Dial In (International):+1-862-298-0850

Webcast URL: https://www.investornetwork.com/event/presentation/56804

Attendees may submit questions during the QA portion of the conference call. 

After November 14th, the webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls. The voice recording will also be available through November 21, 2019 by dialing (Toll Free) 877-481-4010 or (International) 919-882-2331 and entering conference ID number 56804. 

About Aemetis

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries.  Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto.  Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe.  Aemetis is building a dairy digester, pipeline and gas conditioning system near its plant in California to produce below zero carbon content Renewable Natural Gas (RNG).  Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals.  For additional information about Aemetis, please visit  www.aemetis.com.

External Investor Relations

Contact:

Kirin Smith

PCG Advisory Group

(646) 863-6519

ksmith@pcgadvisory.com

Investor Relations/

Media Contact:

Todd Waltz

(408) 213-0940

investors@aemetis.com